What is the Dangote IPO?

“The Dangote IPO” is shorthand for a planned stock market listing of Dangote Petroleum Refinery & Petrochemicals, the 650,000-barrel-per-day refinery built by Nigerian industrialist Aliko Dangote in the Lekki Free Zone, Lagos.

An IPO, or initial public offering, is when a private company sells shares to the public for the first time so anyone can buy a piece of it through a stock exchange — in this case, the Nigerian Exchange (NGX).

Here’s what’s actually confirmed.

The refinery itself is real and operating: it was commissioned in May 2023, began processing crude in early 2024, and the company said in February 2026 that it had reached its full designed capacity of 650,000 barrels per day.

In late July/early August 2026, Dangote Petroleum Refinery formally filed an IPO application with Nigeria’s Securities and Exchange Commission (SEC), according to SEC Director-General Emomotimi Agama and multiple Nigerian business outlets. That filing is a real, verifiable step — it’s not the same as an approved offer.

What isn’t confirmed yet: an official listing date, an approved prospectus, a share price, or the exact percentage of the company being offered.

Aliko Dangote has publicly targeted a September 2026 listing, and the SEC has said it doesn’t currently expect delays, but no date has been formally approved as of this writing.

Reported valuation estimates for the refinery have ranged widely — from roughly $39 billion to $50 billion — but these are analyst and media estimates, not an official IPO valuation set by the company or its underwriters.

It’s also worth knowing that in June 2026, the SEC had to publicly order a halt to unauthorized promotional campaigns soliciting advance subscriptions before any application existed.

If you see anyone online asking you to “pre-register” or send money to secure Dangote shares, treat that as a red flag until Daba or a licensed broker confirms an official subscription window is open.

For everyday investors, the practical takeaway is simple: the deal has moved from rumor to a real regulatory process, but the specifics that actually matter for deciding whether to invest — price, size, timing — aren’t public yet.

That’s normal for this stage of an IPO. The next concrete milestone to watch is SEC approval of a prospectus, which is when real numbers start to appear.

How to participate in the Dangote IPO with Daba

The Dangote IPO has not yet been priced, allocated or opened for subscription.

When the official subscription window opens, Daba will facilitate participation for its eligible account-holders internationally, through Daba’s compliant Nigerian-market channel operated in partnership with a licensed Nigerian securities broker. The executing partner is a SEC-Nigeria-licensed capital-market operator and NGX dealing member.

If you would like to be positioned to participate when the window opens, we suggest the following five steps.

None of these steps commits you to invest.

1. Create your Daba account. Create a Daba account at dabafinance.com/register — takes a few minutes.

2. Pick individual or business. Choose whether to onboard as an individual or as a business / entity (trust, personal investment company, family investment vehicle). Both are supported. Business onboarding is somewhat more document-intensive but the access, execution and repatriation mechanics are identical.

3. Complete KYC (and KYB for businesses). Provide the documents requested by Daba’s onboarding flow. This is a one-time step that unlocks access to every product on the Daba platform, not just the Dangote IPO.

4. Check the rules in your own jurisdiction. Participation in a foreign securities offering may be subject to the rules of your own country of residence — including registration, tax and reporting obligations. You are responsible for understanding and complying with those rules. If in doubt, consult a qualified adviser in your jurisdiction. Daba does not provide tax, legal or investment advice.

5. Express your interest via the Daba interest form. Once your account is KYC-approved, complete the Dangote IPO interest form on the Daba platform. Expressing interest is not an application to subscribe; it lets Daba notify you the moment the official subscription window opens, with the prospectus-approved terms, minimum lot, funding instructions and application deadline. When notified, you will be able to fund your Daba account and submit a subscription application through the Daba platform, subject to Daba’s onboarding checks and to allocation by the issuer’s appointed bookrunners.

Daba does not guarantee allocation. Allocation is determined by the issuer and its appointed bookrunners under the terms of the SEC-Nigeria-approved prospectus. Nothing on this page constitutes an offer to sell, a solicitation to buy or a recommendation to invest in any security.

---

DISCLAIMER

This article is published for informational and educational purposes only. It is not, and does not contain, an offer to sell or a solicitation of an offer to buy any securities, and it is not, and does not contain, investment advice, tax advice or a personal recommendation.

Any future participation in the Dangote Petroleum Refinery & Petrochemicals IPO referenced in this hub is subject to (i) the terms of the issuer’s official SEC-Nigeria-approved prospectus, once and if published; (ii) allocation processes conducted by the Nigerian Exchange, Nigeria’s Securities and Exchange Commission and the issuer’s appointed bookrunners — Daba does not determine or guarantee allocation; (iii) the eligibility of the investor under the laws applicable to that investor in the investor’s country of residence, which the investor is responsible for verifying; and (iv) Daba’s onboarding, KYC and CCI (Certificate of Capital Importation) requirements.

Daba will facilitate participation for its eligible account-holders internationally through a partnership with a SEC Nigeria- licensed capital-market operator and NGX dealing member. Investment in securities involves risk, including risk of loss of principal. Past performance is not indicative of future results.